Resources

Type of publications
Regions
Diseases

5255 results found

2022 ∙ Mehta, N. Shah, S. Paudel, K. Chamlagain, R. Chhetri, S.

Safety and efficacy of coronavirus disease-19 vaccines in chronic kidney disease patients under maintenance hemodialysis: A systematic review

  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Tian, F. Yang, R.

Safety and Efficacy of COVID-19 Vaccines in Children and Adolescents: a Systematic Review of Randomized Controlled Trials

  • Newborn
  • Children
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Lopez-Olivo, M. A. Valerio, V. Karpes Matusevich, A. R. Brizio, M. Kwok, M. Geng, Y. Suarez-Almazor, M. E. Colmegna, I.

Safety and Efficacy of Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitors. Systematic Review with Meta-Analysis

  • All age groups
  • Influenza
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Xu, W. Tang, J. Chen, C. Wang, C. Wen, W. Cheng, Y. Zhou, M. Wu, Q. Zhang, X. Feng, Z. Wang, M.

Safety and efficacy of the COVID-19 vaccine in children and/or adolescents:A meta-analysis

  • Children
  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Simayi, A. Zhu, L. Jin, H.

Safety and Immunogenicity of Pertussis Vaccine Immunization during Pregnancy: A Meta-Analysis of Randomized Clinical Trials

  • Pregnant women
  • Pertussis
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Yeasmin, M. Molla, M. M. A. Masud, H. M. A. A. Saif-Ur-Rahman, K. M.

Safety and immunogenicity of Zika virus vaccine: A systematic review of clinical trials

  • Adults
  • Zika
  • Safety
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Katoto, P. D. M. C. Brand, A. S. Byamungu, L. N. Tamuzi, J. L. Mahwire, T. C. Kitenge, M. K. Wiysonge, C. S. Gray, G.

Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12-17 years: A systematic review and meta-analysis

  • Adolescents
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Chen, H. Zhang, X. Lin, G. Gong, F. Hocher, B.

Safety of COVID-19 vaccination in women undergoing IVF/ICSI treatment - Clinical study and systematic review

  • Western Pacific
  • China
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Zheng, Q. Ma, P. Feng, Z.

Safety of COVID-19 vaccine in patients with epilepsy: a meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ James, D. Jena, A. Bharath, P. N. Choudhury, A. Singh, A. K. Sebastian, S. Sharma, V.

Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
Loading...